Bristol-Myers
Squibb Company (NYSE:BMY) will take part in the Leerink Swann Global
Health Care Conference on Thursday, February 12, 2015, in New York. Francis
Cuss, executive vice president and chief scientific officer, will
answer questions about the company at 11:10 a.m. EST.
Investors and the general public are invited to listen to a live webcast
of the session at http://investor.bms.com.
An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information, please
visit www.bms.com
or follow us on Twitter at http://twitter.com/bmsnews.
Bristol-Myers Squibb CompanyMedia:Ken Dominski, 609-252-5251ken.dominski@bms.comorInvestors:Ranya Dajani, 609-252-5330Ranya.dajani@bms.com